Skip to main content
Veterinary Medicines

DACLOTRIX 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg

Authorised
  • Permethrin (40:60)
  • Imidacloprid

Product identification

Medicine name:
DACLOTRIX 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg
DACLOTRIX 500 mg/100 mg SOLUCION PARA UNCION DORSAL PUNTUAL PARA PERROS DE MAS DE 4 KG HASTA 10 KG
Active substance:
  • Permethrin (40:60)
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Permethrin (40:60)
    500.00
    milligram(s)
    /
    1.00
    Pipette
  • Imidacloprid
    100.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 4068 ESP
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0774/002
Concerned member states:
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 6/07/2025
Download
Spanish (PDF)
Published on: 8/09/2025

Combined File of all Documents

English (PDF)
Published on: 6/07/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/09/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 8/09/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."